JAKKS Pacific (JAKK) Q2 Earnings Miss Estimates, Margin Falls
JAKKS Pacific, Inc.’s JAKK reported dismal results in second-quarter 2018, wherein both the top and the bottom lines missed the Zacks Consensus Estimate. The company incurred adjusted loss of 72 cents per share, wider than the consensus mark of loss of 50 cents. In the year-ago quarter, the company had incurred a loss of 63 cents per share.
Net sales totaled $105.8 million, which lagged the consensus mark of $115 million by 8%. The top line also fell 11.5% on a year-over-year basis. Notably, the challenging industry scenario for traditional toymakers has affected JAKKS Pacific’s second-quarter results. Furthermore, the company stated that the Toys ‘R’ Us bankruptcy was another reason behind its disappointing performance in the quarter. Per JAKKS Pacific, the positive contribution of products like Incredibles 2, Squish-Dee-Lish, and MorfBoard was overshadowed by the Toys ‘R’ Us bankruptcy.
In the past six months, shares of JAKKS Pacific have lost 9.4% against the industry’s 13.1% rise.
In the quarter under review, gross margin was 26.4%, down 180 basis points (bps) from the prior-year quarter. The metric was negatively impacted by rise in sales reserves and lower selling prices for certain licensed products at the end of the cycle.
Adjusted EBITDA was negative $8.5 million compared with negative $5.4 million in the prior-year quarter.
JAKKS Pacific, Inc. Price, Consensus and EPS Surprise
JAKKS Pacific, Inc. Price, Consensus and EPS Surprise | JAKKS Pacific, Inc. Quote
As of Jun 30, 2018, cash and cash equivalents were $63 million compared with $46.8 million as of Mar 31, 2018. Inventory increased to $62.2 million from $58.4 million at the end of Dec 31, 2017. Long-term debt as on Jun 30, 2018, totaled $137.3 million, up from $133.5 million at the end of 2017.
JAKKS Pacific, which shares space with Glu Mobile Inc. GLUU, Hasbro Inc. HAS and Activision Blizzard, Inc. ATVI, currently carries a Zacks Rank #2 (Buy). However, this bullish rank is subject to change following the earnings announcement. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
JAKKS Pacific, Inc. (JAKK) : Free Stock Analysis Report
Hasbro, Inc. (HAS) : Free Stock Analysis Report
Activision Blizzard, Inc (ATVI) : Free Stock Analysis Report
Glu Mobile Inc. (GLUU) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research